Parameter | Variable | Minimum value | Delta costs a | Maximum value | Delta Costs a | |
---|---|---|---|---|---|---|
Base case, model timeframe 4 years, starting age 75 years Discounted by 3% | M F | 44.85 € 19.31 € | ||||
pAF | Undetected AF in % of detected AF population (base case: 33%) | M F | 10% | −21.91 € −29.57 € | 70% | 149.75 € 96.13 € |
cStroke_ Factor | Scaling factor stroke costs 100% = base case | M F | 50% | 6.85 € −7.94 € | 150% | 82.84 € 46.57 € |
RSA_Factor | Scaling factor RSA compensation payments; base case: factor 1.0 | M F | 0.0 | −48.57 € −50.53 € | 1.25 | 68.20 € 36.77 € |
orStroke_AF_ reduction | Effectiveness of stroke prevention 0% - no effect; base case: 70% | M F | 40% | 14.87 € −2.51 € | 90% | 65.86 € 34.58 € |
AgeStart | Starting age of the population Base case: 75 years old | M F | 65 years old | −20.72 € −36.56 € | 85 years old | 109.05 € 71.69 € |
orStroke_AF_ NOATT | Increased stroke rate with AF without prevention; Base case: factor 4.2 | M F | 2.0 | 13.81 € −3.48 € | 5.0 | 55.05 € 26.85 € |
cTest_Factor | Scaling factor screening costs 100% = base case (€47.54 / €297.50) | M F | 50% | 52.52 € 25.27 € | 500% | −16.55 € −28.33 € |
orMortAF_base | Increased background mortality, AF subpop. 25% increase = base case | M F | 0% | 48.17 € 20.99 € | 75% | 38.77 € 16.19 € |
Discount rate | Discount factor 3% = base case | M F | 1% | 48.42 € 21.99 € | 5% | 41.51 € 16.82 € |